Agilent Technologies will be on site throughout next week at the European Peptide Symposium to cover peptide-related analytical needs for colleagues in Europe, Middle East, and Africa.
Published
Signal category
Presence & Recognition
Quote
“Our Agilent Europe, Middle East & Africa colleagues will also be on site throughout next week to cover all of your peptide-related analytical needs”
— Dr. Vitan Blagotinsek|Agilent Technologies team
Company
Agilent Technologies
Let’s Bring Great Science to Life.
- Industry
- Biotechnology Research
- Location
- Santa Clara, US
- Company size
- 18,260 employees
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life. In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.
Founded 1999